In a landmark advancement for the treatment of limited-stage small cell lung cancer (LS-SCLC), researchers at the National Cancer Center…

Pfizer veteran Suneet Varma has found his next role. Months after leaving the Big Pharma, Varma has taken the CEO position…

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a…

In a groundbreaking advancement in materials science, researchers from Japan and Taiwan have unveiled a novel approach to the anisotropic…

In the rapidly evolving realm of psychiatric genomics, Dr. Oliver Pain stands as a visionary transforming our understanding of complex…

Dr. Gerhard Andersson, a notable figure in psychological research, has garnered attention for his significant contributions to the evolution of…

In a rapidly evolving landscape of healthcare, patient preferences and their understanding of treatments are pivotal to the success of…

Recent advances in the understanding of hepatocellular carcinoma (HCC), a prevalent form of liver cancer, have highlighted the need for…

In the realm of pediatric surgery, the investigation and management of vascular anomalies, particularly those involving the portal vein, have…

Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed…